FIELD: medicine. SUBSTANCE: method deals with an active complex that includes a structure component, at least one activation and formation component and at least one growth and maturation component the distinctive feature of which is that to obtain biological units, the organs of living organisms in particular, it additionally contains at least one adhesion component, moreover the structure component is designed as a gel and/or reticular structure. EFFECT: higher efficiency at organogenesis. 4 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING ACTIVE COMPLEX TO BE APPLIED IN BIOLOGY | 1992 |
|
RU2121370C1 |
| BIOACTIVE COMPLEX FOR ORGANOGENESIS | 2003 |
|
RU2254146C2 |
| ENDOPROSTHESIS OF LONG-TERM STABILITY | 2000 |
|
RU2260446C2 |
| IMPLANT FOR REPAIRING VERTEBRAE AND TUBULAR BONES | 2000 |
|
RU2261116C2 |
| PHARMACEUTICAL COMPOSITIONS AIMED AT Erb-B1 RECEPTORS | 2003 |
|
RU2354402C2 |
| COMPOSITIONS AND METHODS FOR REGULATION OF VESSELS DEVELOPMENT | 2005 |
|
RU2365382C2 |
| GENETICALLY MODIFIED CELLS AND THEIR APPLICATION FOR PROPHYLAXIS OR TREATMENT OF SICKNESSES | 1998 |
|
RU2205029C2 |
| ACELLULAR TRANSPLANT | 2006 |
|
RU2404820C2 |
| METHOD FOR NEOGENESIS | 2004 |
|
RU2542391C2 |
| DERIVED FROM HUMAN THROMBOCYTE LYSATE, EXTRACELLULAR VESICLES FOR USE IN MEDICINE | 2017 |
|
RU2735139C2 |
